Periocular capillary hemangioma: management practices in recent years

Figures & data

Table 1 Patients’ characteristics

	Number of cases	%
No of patients	16
Male:female	1:3
Median age at consultation	4 months (1–72 months)
Preterm	3	19
Term	13	81
Race
Caucasian	1	6
Chinese	9	56
Indian	2	13
Malay	3	19
Others	1	6

Figure 1 Types of hemangioma according to depth of involvement.

Notes: (A) Superficial left upper-eyelid hemangioma. (B) Subcutaneous left lower-eyelid hemangioma. (C) Combined superficial and subcutaneous hemangioma in the glabella.

Table 2 Mean visual acuity, and sphere and cylinder refraction at first and last visits

	First visit	Latest visit
UCVA (logMAR)	0.77 (range: 0.1 to 1.68)	0.46 (range: 0.1 to 0.67)
Mean sphere	+1.83 (range: +0.25 to +3.50)	+1.00 (range: −0.50 to +2.50)
Mean cylinder	−1.63 (range: −0.75 to −4.25)	−1.28 (range: 0.00 to −4.00)

Abbreviations: UCVA, uncorrected visual acuity; logMar, logarithm of the minimum angle of resolution.

Table 3 Modes of treatment used for periocular capillary hemangiomas in this series

	n
Single treatment	4
Combined treatment	3
Management
Observation	9
Topical timolol maleate 0.5%	1
Intralesional triamcinolone/bethamethasone	1
Intralesional bleomycin	1
Oral prednisolone	2
Oral propranolol	3
Surgical excision	2

Figure 2 Photograph of one case of capillary hemangioma that resolved spontaneously without treatment at (A) 4 months old upon first visit and at (B) 5 years old upon latest visit.

Figure 3 A 6-month-old female with combined superficial and deep hemangioma over the right superior orbit with inferior globe displacement.

Note: Pretreatment sagittal MRI (left). She received two intralesional bleomycin injections (received at other institutions) and oral propranolol. Clinical photograph taken after commencing treatment (right).
Abbreviation: MRI, magnetic resonance imaging.

Figure 4 Sagittal MRI of a hemangioma involving the left orbit and pterygopalatine fossa before (left) and 1 year after treatment (right) with oral prednisolone.

Abbreviation: MRI, magnetic resonance imaging.